P

Pulmatrix
D

PULM

6.21000
USD
0.16
(2.64%)
Market Closed
Volume
607
EPS
-5
Div Yield
-
P/E
-2
Market Cap
22,680,690
OverviewSignalsIdeasNews
Related Instruments
    A
    ADMP
    0
    (0%)
    0.000000 USD
    A
    AGEN
    -0.05000
    (-1.80%)
    2.72500 USD
    A
    APTX
    0
    (0%)
    0.000000 USD
    B
    BCRX
    -0.41500
    (-5.57%)
    7.03500 USD
    C
    CRBP
    -0.950
    (-5.41%)
    16.610 USD
    D
    DVAX
    -1.180
    (-8.81%)
    12.210 USD
    M
    MNOV
    0.04000
    (2.17%)
    1.88000 USD
    T
    TGTX
    -1.325
    (-4.30%)
    29.515 USD
    V
    VKTX
    -3.960
    (-7.39%)
    49.620 USD
    X
    XENE
    -1.920
    (-4.60%)
    39.850 USD
    More
News

Title: Pulmatrix

Sector: Healthcare
Industry: Biotechnology
Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmetmedical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.